Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for Hospitalized COVID-19 Patients
NCT04559113Unknown
- Sponsor
- Lahore General Hospital
- Start
- May 2020
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of methylprednisolone injection in coronavirus disease 2019 (COVID-19), sponsored by Lahore General Hospital. Primary endpoint: Clinical response after administration at 10 days. Status: unknown.
02
Drugs
methylprednisolone injection
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04559113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04559113.